이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 1997. 5. 27.1 분 읽기
Oral Dosage Form New Animal Drugs; Milbemycin Oxime/Lufenuron Tablets
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The NADA provides for use of milbemycin oxime/lufenuron tablets for prevention of heartworm disease caused by Dirofilaria immitis, control of adult Ancylostoma caninum, the removal and control of adult Toxocara canis, Toxascaris leonina, and Trichuris vulpis infections, and the prevention and control of flea populations in dogs.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →